These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1160 related articles for article (PubMed ID: 18566575)

  • 21. Adipocyte differentiation of human marrow mesenchymal stem cells reduces the supporting capacity for hematopoietic progenitors but not for severe combined immunodeficiency repopulating cells.
    Ookura N; Fujimori Y; Nishioka K; Kai S; Hara H; Ogawa H
    Int J Mol Med; 2007 Mar; 19(3):387-92. PubMed ID: 17273785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum.
    Nimura A; Muneta T; Koga H; Mochizuki T; Suzuki K; Makino H; Umezawa A; Sekiya I
    Arthritis Rheum; 2008 Feb; 58(2):501-10. PubMed ID: 18240254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis.
    Papadaki HA; Tsagournisakis M; Mastorodemos V; Pontikoglou C; Damianaki A; Pyrovolaki K; Stamatopoulos K; Fassas A; Plaitakis A; Eliopoulos GD
    Bone Marrow Transplant; 2005 Dec; 36(12):1053-63. PubMed ID: 16205726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of hematopoiesis in Dexter-type long-term cultures established from human umbilical cord blood cells.
    Mayani H; Gutiérrez-Rodríguez M; Espinoza L; López-Chalini E; Huerta-Zepeda A; Flores E; Sánchez-Valle E; Luna-Bautista F; Valencia I; Ramírez OT
    Stem Cells; 1998; 16(2):127-35. PubMed ID: 9554037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.
    Astori G; Malangone W; Adami V; Risso A; Dorotea L; Falasca E; Marini L; Spizzo R; Bigi L; Sala P; Tonutti E; Biffoni F; Rinaldi C; Del Frate G; Pittino M; Degrassi A
    Blood Cells Mol Dis; 2001; 27(4):715-24; discussion 725-7. PubMed ID: 11778655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy.
    Pérez-Ilzarbe M; Díez-Campelo M; Aranda P; Tabera S; Lopez T; del Cañizo C; Merino J; Moreno C; Andreu EJ; Prósper F; Pérez-Simón JA
    Transfusion; 2009 Sep; 49(9):1901-10. PubMed ID: 19497059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Equine peripheral blood-derived progenitors in comparison to bone marrow-derived mesenchymal stem cells.
    Koerner J; Nesic D; Romero JD; Brehm W; Mainil-Varlet P; Grogan SP
    Stem Cells; 2006 Jun; 24(6):1613-9. PubMed ID: 16769763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
    Ruggieri L; Heimfeld S; Broxmeyer HE
    Blood Cells; 1994; 20(2-3):436-54. PubMed ID: 7538350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells.
    Panepucci RA; Siufi JL; Silva WA; Proto-Siquiera R; Neder L; Orellana M; Rocha V; Covas DT; Zago MA
    Stem Cells; 2004; 22(7):1263-78. PubMed ID: 15579645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cotransplantation with MSCs improves engraftment of HSCs after autologous intra-bone marrow transplantation in nonhuman primates.
    Masuda S; Ageyama N; Shibata H; Obara Y; Ikeda T; Takeuchi K; Ueda Y; Ozawa K; Hanazono Y
    Exp Hematol; 2009 Oct; 37(10):1250-1257.e1. PubMed ID: 19638293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
    Mauney JR; Volloch V; Kaplan DL
    Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro clinical-grade generation of red blood cells from human umbilical cord blood CD34+ cells.
    Baek EJ; Kim HS; Kim S; Jin H; Choi TY; Kim HO
    Transfusion; 2008 Oct; 48(10):2235-45. PubMed ID: 18673341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonadherent cell population of human marrow culture is a complementary source of mesenchymal stem cells (MSCs).
    Wan C; He Q; McCaigue M; Marsh D; Li G
    J Orthop Res; 2006 Jan; 24(1):21-8. PubMed ID: 16419965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of primary culture condition for mesenchymal stem cells derived from umbilical cord blood with factorial design.
    Fan X; Liu T; Liu Y; Ma X; Cui Z
    Biotechnol Prog; 2009; 25(2):499-507. PubMed ID: 19319963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts.
    Chen XD; Dusevich V; Feng JQ; Manolagas SC; Jilka RL
    J Bone Miner Res; 2007 Dec; 22(12):1943-56. PubMed ID: 17680726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effective ex vivo expansion of hematopoietic stem cells using osteoblast-differentiated mesenchymal stem cells is CXCL12 dependent.
    Mishima S; Nagai A; Abdullah S; Matsuda C; Taketani T; Kumakura S; Shibata H; Ishikura H; Kim SU; Masuda J
    Eur J Haematol; 2010 Jun; 84(6):538-46. PubMed ID: 20088916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion.
    Jootar S; Pornprasertsud N; Petvises S; Rerkamnuaychoke B; Disthabanchong S; Pakakasama S; Ungkanont A; Hongeng S
    Leuk Res; 2006 Dec; 30(12):1493-8. PubMed ID: 16839603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term hematopoietic culture-initiating cells are more abundant in mobilized peripheral blood grafts than in bone marrow but have a more limited ex vivo expansion potential.
    Srour EF; Bregni M; Traycoff CM; Agüero B; Kosak ST; Hoffman R; Siena S; Gianni AM
    Blood Cells Mol Dis; 1996; 22(1):68-81. PubMed ID: 8807087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.